⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TENX News
Tenax Therapeutics, Inc.
Tenax Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Tenax Therapeutics (TENX)
prnewswire.com
TENX
Tenax Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Tenax Therapeutics, Inc. (TENX)
accessnewswire.com
TENX
Tenax Therapeutics, Inc. (NASDAQ: TENX) Investors: Johnson Fistel Investigates Potential Securities Law Violations After Phase 3 Trial Failure; Shares Plummet Nearly 90%
globenewswire.com
TENX
Form 8-K
sec.gov
TENX
Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint
globenewswire.com
TENX
Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF
globenewswire.com
TENX
Form 8-K
sec.gov
TENX
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
TENX
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TENX
Form 8-K
sec.gov
TENX